MUDr. David Funda, Ph.D.

Researcher

Publication

Diabetes Research and Clinical Practice. 2024; 217(November); 111844

Low-carbohydrate diet in children and young people with type 1 diabetes: A randomized controlled trial with cross-over design

Frontiers in Endocrinology. 2023; 14); 1270297

The gut-pancreas axis in type 1 diabetes a focus on environmental factors

Nutrients. 2023; 15(2); 454

Protective Effect of Vegan Microbiota on Liver Steatosis Is Conveyed by Dietary Fiber: Implications for Fecal Microbiota Transfer Therapy

Acta Pathologica Microbiologica et Immunologica Scandinavica. 2023; 131(6); 237-248

Reduced phosphatidylcholine level in the intestinal mucus layer of prediabetic NOD mice

Journal of Applied Biomedicine. 2023; 21(4); 167-173

Olfactory event-related potentials (OERPs) and trigeminal event-related potentials (TERPs) a pilot study in Czech participants with normal sense of smell

Cell Reports. 2022; 41(3); 111478

Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protection

Journal of Clinical Medicine. 2022; 11(22); 6628

Olfactory Evaluation in Clinical Medical Practice

Kidney & Blood Pressure Research. 2021; 46(2); 245-249

Local angiotensin-converting enzyme 2 gene expression in kidney allografts is not affected by renin-angiotensin-aldosterone inhibitors

Diabetes Obesity & Metabolism. 2020; 22(5); 866-872

Gluten-free diet in children with recent-onset type 1 diabetes: A 12-month intervention trial

Diabetologia. 2019; 62(7); 1291-1296

Human gut microbiota transferred to germ-free NOD mice modulate the progression towards type 1 diabetes regardless of the pace of beta cell function loss in the donor

Frontiers in Immunology. 2019; 10(MAY 14); 967

Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?